Coya Therapeutics, Inc. (COYA)
NASDAQ·Healthcare·Biotechnology
$4.27
-3.07%
Mkt Cap $80.42M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $2.25M | $4.00M | +78.04% | -$0.27 | -$0.34 | -24.77% | — | — |
| Q4 2025 Nov 12, 2025 | $1.93M | $3.56M | +85.14% | $0.02 | -$0.10 | -600.00% | — | — |
| Q3 2025 Aug 12, 2025 | $783.33K | $163.62K | -79.11% | -$0.22 | -$0.36 | -63.64% | — | — |
| Q2 2025 May 13, 2025 | $2.63M | $257.88K | -90.21% | -$0.44 | -$0.44 | +0.00% | — | — |
| Q1 2025 Mar 18, 2025 | $100.00K | $1.95K | -98.05% | -$0.26 | -$0.18 | +30.77% | — | — |
| Q4 2024 Nov 6, 2024 | $1.88M | — | — | -$0.41 | -$0.26 | +36.59% | — | — |
| Q3 2024 Aug 12, 2024 | $2.75M | $3.43M | +24.56% | -$0.14 | -$0.19 | -35.71% | — | — |
| Q2 2024 May 9, 2024 | — | $126.84K | — | -$0.30 | -$0.35 | -16.67% | — | — |
| Q1 2024 Mar 19, 2024 | $7.50M | $6.00M | -19.97% | $0.26 | $0.15 | -42.31% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.37 | -$0.34 | +8.11% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.32 | -$0.31 | +3.13% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$0.43 | -$0.28 | +34.88% | — | — |
| Q1 2023 Mar 29, 2023 | — | — | — | — | -$0.42 | — | — | — |
| Q4 2022 Dec 30, 2022 | — | — | — | — | -$0.52 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.42 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.26 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.25 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.14 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.37 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.37 | — | — | — |